We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04721015
Brief Title: Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

First Submitted : January 20, 2021
First Submitted that Met QC Criteria : January 20, 2021
First Posted : January 22, 2021

Last Update Submitted that Met QC Criteria : September 12, 2022
Last Update Posted : September 13, 2022